|CAS Number||132-65-0||Molecular Weight||184.257|
|Density||1.3±0.1 g/cm3||Boiling Point||332.5±11.0 °C at 760 mmHg|
|Molecular Formula||C12H8S||Melting Point||97-100 °C(lit.)|
|MSDS||Chinese USA||Flash Point||114.8±5.5 °C|
Use of Dibenzothiophene
Dibenzothiophene is an intermediate of organic synthesis, consisting of two benzene rings fused to a central thiophene ring.
|Description||Dibenzothiophene is an intermediate of organic synthesis, consisting of two benzene rings fused to a central thiophene ring.|
DMSO : ≥ 125 mg/mL (678.39 mM)
* "≥" means soluble, but saturation unknown.
4°C, protect from light
|Shipping||Room temperature in continental US; may vary elsewhere|
|Related Molecules||Captisol | Cyclosporin A | H2DCFDA | MPTP (hydrochloride) | GW4869 | Etomoxir | TD139 | Mitoquinone mesylate | GSK2795039 | JC-1 | Bapta-am | AP20187 | GKT137831 | D-Luciferin | Monocrotaline|
*The above documents are provided by Medchemexpress and are for scientific research only.
|Boiling Point||332.5±11.0 °C at 760 mmHg|
|Melting Point||97-100 °C(lit.)|
|Flash Point||114.8±5.5 °C|
|Vapour Pressure||0.0±0.7 mmHg at 25°C|
|Index of Refraction||1.756|
Synonym:2,2'-Biphenylylene sulfide; 9-Thiafluorene; Dibenzo(b,d)thiophene; Diphenylene sulfide
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: 22
Section 3 - HAZARDS IDENTIFICATION
Harmful if swallowed.
Potential Health Effects
May cause eye irritation.
May cause skin irritation.
Harmful if swallowed. Causes gastrointestinal irritation with nausea, vomiting and diarrhea.
May cause respiratory tract irritation.
Chronic ingestion may cause liver damage.
Section 4 - FIRST AID MEASURES
Eyes: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Get medical aid.
In case of contact, flush skin with plenty of water. Remove contaminated clothing and shoes. Get medical aid if irritation develops and persists. Wash clothing before reuse.
If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious person. Get medical aid.
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Section 5 - FIRE FIGHTING MEASURES
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. This material in sufficient quantity and reduced particle size is capable of creating a dust explosion.
Use water spray, dry chemical, carbon dioxide, or chemical foam.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Vacuum or sweep up material and place into a suitable disposal container. Avoid generating dusty conditions. Provide ventilation.
Section 7 - HANDLING and STORAGE
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Avoid breathing dust.
Store in a cool, dry place. Store in a tightly closed container.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 132-65-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Wear appropriate gloves to prevent skin exposure.
Wear appropriate protective clothing to minimize contact with skin.
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Crystalline powder
Color: yellow to green
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 332 - 333 deg C @ 760 mm Hg
Freezing/Melting Point: 97 - 100 deg C
Autoignition Temperature: > 450 deg C (> 842.00 deg F)
Flash Point: 170 deg C ( 338.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Solubility in water: soluble
Molecular Formula: C12H8S
Molecular Weight: 184.26
Section 10 - STABILITY AND REACTIVITY
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported.
Section 11 - TOXICOLOGICAL INFORMATION
CAS# 132-65-0: HQ3490550 LD50/LC50:
CAS# 132-65-0: Oral, mouse: LD50 = 470 mg/kg.
Dibenzothiophene - Not listed by ACGIH, IARC, or NTP.
See actual entry in RTECS for complete information.
Section 12 - ECOLOGICAL INFORMATION
Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - TRANSPORT INFORMATION
Not regulated as a hazardous material.
Not regulated as a hazardous material.
Shipping Name: Not regulated.
Section 15 - REGULATORY INFORMATION
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
R 22 Harmful if swallowed.
WGK (Water Danger/Protection)
CAS# 132-65-0: No information available.
CAS# 132-65-0 is listed on Canada's DSL List.
CAS# 132-65-0 is not listed on Canada's Ingredient Disclosure List.
CAS# 132-65-0 is listed on the TSCA inventory.
SECTION 16 - ADDITIONAL INFORMATION
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
|Personal Protective Equipment||dust mask type N95 (US);Eyeshields;Faceshields;Gloves|
|Summary||2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%|
Infection of human amniotic and endothelial cells by Japanese encephalitis virus: Increased expression of HLA-F.
Virology 471-473 , 29-37, (2015)
Productive infection of human amniotic and endothelial cell lines with Japanese encephalitis virus (JEV) was established leading to the induction of NFκB and HLA-F, a non-classical MHC molecule. Induc...
Detailed compositional characterization of plastic waste pyrolysis oil by comprehensive two-dimensional gas-chromatography coupled to multiple detectors.
J. Chromatogr. A. 1359 , 237-46, (2014)
The detailed compositional characterization of plastic waste pyrolysis oil was performed with comprehensive two-dimensional GC (GC×GC) coupled to four different detectors: a flame ionization detector ...
Convenient QSAR model for predicting the complexation of structurally diverse compounds with β-cyclodextrins
Bioorg. Med. Chem. 17 , 896-904, (2009)
This paper reports a QSAR study for predicting the complexation of a large and heterogeneous variety of substances (233 organic compounds) with beta-cyclodextrins (beta-CDs). Several different theoret...